American International Group’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-21,492
| Closed | -$126K | – | 3253 |
|
|
2019
Q1 | $126K | Sell |
21,492
-696
| -3% | -$2.37K | ﹤0.01% | 2491 |
|
|
2018
Q4 | $29K | Sell |
22,188
-172
| -0.8% | -$299 | ﹤0.01% | 2988 |
|
|
2018
Q3 | $77K | Buy |
22,360
+404
| +2% | +$1.52K | ﹤0.01% | 2948 |
|
|
2018
Q2 | $100K | Buy |
21,956
+1,470
| +7% | +$5.86K | ﹤0.01% | 2788 |
|
|
2018
Q1 | $68K | Sell |
20,486
-1,102
| -5% | -$3.9K | ﹤0.01% | 2824 |
|
|
2017
Q4 | $84K | Buy |
21,588
+10,156
| +89% | +$55.3K | ﹤0.01% | 2805 |
|
|
2017
Q3 | $118K | Buy |
11,432
+855
| +8% | +$8.41K | ﹤0.01% | 2576 |
|
|
2017
Q2 | $103K | Buy |
10,577
+3,579
| +51% | +$25.1K | ﹤0.01% | 2718 |
|
|
2017
Q1 | $48K | Buy |
6,998
+566
| +9% | +$3.27K | ﹤0.01% | 2850 |
|
|
2016
Q4 | $35K | Sell |
6,432
-17
| -0.3% | -$120 | ﹤0.01% | 2919 |
|
|
2016
Q3 | $48.9K | Buy |
6,449
+9
| +0.1% | +$66 | ﹤0.01% | 2899 |
|
|
2016
Q2 | $52.5K | Sell |
6,440
-188
| -3% | -$2.35K | ﹤0.01% | 2934 |
|
|
2016
Q1 | $86K | Hold |
6,628
| – | – | ﹤0.01% | 3548 |
|
|
2015
Q4 | $133K | Sell |
6,628
-12
| -0.2% | -$207 | ﹤0.01% | 3239 |
|
|
2015
Q3 | $81K | Buy |
6,640
+7
| +0.1% | +$131 | ﹤0.01% | 3644 |
|
|
2015
Q2 | $137K | Buy |
6,633
+2,803
| +73% | +$66.2K | ﹤0.01% | 3397 |
|
|
2015
Q1 | $80.9K | Hold |
3,830
| – | – | ﹤0.01% | 3720 |
|
|
2014
Q4 | $118K | Buy |
+3,830
| New | +$106K | ﹤0.01% | 3444 |
|
American International Group's IMDZ Position: Q2 2019 in Review
American International Group sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 21,492 shares — an estimated $126K sold.
American International Group first reported a position in IMDZ in Q4 2014 and held it in 18 quarters. The position peaked at $137K in Q2 2015. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- American International Group reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- American International Group sold 21,492 Immune Design Corp. shares in Q2 2019, an estimated $126K.
- American International Group first reported a position in Immune Design Corp. in Q4 2014 and held it in 18 quarters.
- American International Group's Immune Design Corp. position peaked at $137K in Q2 2015.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on American International Group's 13F filing for Q2 2019, filed 13 Aug 2019.